Real World Outcomes With Chemotherapy and Immunotherapy in Metastatic Poorly Differentiated Gastroenteropancreatic Neuroendocrine Carcinomas

ABSTRACT Background Gastroenteropancreatic poorly differentiated neuroendocrine carcinomas (GEP‐NECs) are aggressive cancers where cytotoxic chemotherapy is the backbone of treatment. While the addition of immunotherapy with immune checkpoint inhibitors (IOs) to chemotherapy is recommended for lung...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Rushabh Gujarathi, Samantha Kwock, Faith Abodunrin, Namrata Setia, Xavier M. Keutgen, Chih‐Yi Liao
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2026-04-01
coleção:	Cancer Medicine
Assuntos:	chemotherapy immunotherapy ncdb neuroendocrine carcinomas neuroendocrine tumors
Acesso em linha:	https://doi.org/10.1002/cam4.71809
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!